Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

633
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
633
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.2K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

628
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
628

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of the CALLY index in patients undergoing transcatheter aortic valve implantation.

Biomarkers in medicine·2026
Same author

Reply to the Letter to the Editor: "Exploring the Multifaceted Nexus of Hypertrophic Cardiomyopathy and Clinical Outcomes".

Anatolian journal of cardiology·2026
Same author

Prevalence and characteristics of normal electrocardiograms in hypertrophic cardiomyopathy.

Journal of electrocardiology·2026
Same author

Optimising cinefluoroscopy for accurate evaluation of mechanical prosthetic valves.

Acta cardiologica·2026
Same author

Sodium-glucose cotransporter-2 inhibitor use is associated with reduced acute kidney injury after transcatheter aortic valve implantation.

Frontiers in cardiovascular medicine·2026
Same author

Reply to the Letter to the Editor: Addressing the Survival Paradox, Procedural Learning Curve, and Pharmacological Confounding in Patients with Left Ventricular Systolic Dysfunction Undergoing Transcatheter Aortic Valve Replacement.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026

Related Experiment Video

Updated: Mar 21, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K

Asymptomatic Pulmonary Embolism after Ablation.

Gamze Babur Guler1, Mehmet Mustafa Can, Ekrem Guler

  • 1Department of Cardiology, Faculty of Medicine, Medipol University, Istanbul, Turkey.

Cardiology
|May 5, 2016
PubMed
Summary

Asymptomatic pulmonary embolism (PE) occurs in over 8% of atrial fibrillation (AF) patients undergoing ablation. The CHA2DS2-VASc score predicts silent PE, though this finding doesn't alter current clinical practice.

More Related Videos

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K

Related Experiment Videos

Last Updated: Mar 21, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Imaging

Background:

  • Pulmonary embolism (PE) presents variably, from asymptomatic cases to cardiac arrest.
  • The relationship between atrial fibrillation (AF) and PE, specifically whether right atrial emboli cause PE or if PE provokes AF, remains unclear.

Purpose of the Study:

  • To determine the incidence of asymptomatic PE in patients undergoing AF ablation.
  • To identify predictors of asymptomatic PE in this patient population.

Main Methods:

  • Seventy-one AF patients underwent guided ablation with 3D computed tomography.
  • Exclusion criteria included prior symptomatic PE, pulmonary hypertension, and other risk factors.
  • Asymptomatic PE was assessed using the modified Miller score by two independent assessors.

Main Results:

  • The incidence of asymptomatic PE was found to be greater than 8%.
  • Univariate analysis identified age, diabetes, CHA2DS2-VASc score, and pulmonary artery diameter as associated with PE.
  • Multivariate analysis confirmed the CHA2DS2-VASc score as the sole significant predictor of asymptomatic PE.

Conclusions:

  • Asymptomatic PE is common in AF patients undergoing ablation.
  • The CHA2DS2-VASc score effectively predicts silent PE.
  • While current clinical practice remains unchanged, the findings offer insights into the AF-PE causal relationship.